Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer

NCT00301860 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped lack of efficacy

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: melphalan
DRUG: methotrexate
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of California, San Francisco

Collaborators

[object Object]